SI3883647T1 - C10-alkilen substituirani 13-členski makrolidi in njihove uporabe - Google Patents

C10-alkilen substituirani 13-členski makrolidi in njihove uporabe

Info

Publication number
SI3883647T1
SI3883647T1 SI201931026T SI201931026T SI3883647T1 SI 3883647 T1 SI3883647 T1 SI 3883647T1 SI 201931026 T SI201931026 T SI 201931026T SI 201931026 T SI201931026 T SI 201931026T SI 3883647 T1 SI3883647 T1 SI 3883647T1
Authority
SI
Slovenia
Prior art keywords
alkylene substituted
membered macrolides
macrolides
membered
alkylene
Prior art date
Application number
SI201931026T
Other languages
English (en)
Slovenian (sl)
Inventor
Roger B. Clark
Richard Alm
Wesley Francis Austin
Philip Hogan
Ivan Jewett
Sushmita D. Lahiri
Jonathan F. Lawrence
Xiben Li
Shuhao Shi
Wenying Wang
Yoshitaka Ichikawa
Andrew G. Myers
Ziyang Zhang
Peter Niels Carlsen
Andre Sanchez
Ganapathy Dhandapani
Thrimurtulu Neetipalli
Md. Ataur RAHMAN
Thomas Lepitre
Original Assignee
Zikani Therapeutics, Inc.
President And Fellows Of Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68916562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3883647(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zikani Therapeutics, Inc., President And Fellows Of Harvard College filed Critical Zikani Therapeutics, Inc.
Publication of SI3883647T1 publication Critical patent/SI3883647T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI201931026T 2018-11-19 2019-11-18 C10-alkilen substituirani 13-členski makrolidi in njihove uporabe SI3883647T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof
EP19821351.4A EP3883647B1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Publications (1)

Publication Number Publication Date
SI3883647T1 true SI3883647T1 (sl) 2026-04-30

Family

ID=68916562

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201931026T SI3883647T1 (sl) 2018-11-19 2019-11-18 C10-alkilen substituirani 13-členski makrolidi in njihove uporabe

Country Status (19)

Country Link
US (1) US12552825B2 (https=)
EP (2) EP4737470A2 (https=)
JP (2) JP7551610B2 (https=)
KR (1) KR102929869B1 (https=)
CN (1) CN113573779A (https=)
AU (1) AU2019385333B2 (https=)
BR (1) BR112021009624A2 (https=)
CA (1) CA3120148A1 (https=)
DK (1) DK3883647T3 (https=)
ES (1) ES3063764T3 (https=)
FI (1) FI3883647T3 (https=)
IL (1) IL283194B2 (https=)
LT (1) LT3883647T (https=)
MX (1) MX2021005423A (https=)
PT (1) PT3883647T (https=)
SG (1) SG11202105227QA (https=)
SI (1) SI3883647T1 (https=)
SM (1) SMT202600094T1 (https=)
WO (1) WO2020106627A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
CN120152721A (zh) 2022-09-01 2025-06-13 齐卡尼治疗股份有限公司 使用13元大环内酯治疗家族性腺瘤性息肉病

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US20130102551A1 (en) * 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
WO2013004116A1 (zh) * 2011-07-06 2013-01-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) * 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
WO2016154533A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Synthesis of desosamines
US20180273573A1 (en) * 2015-10-01 2018-09-27 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2018201076A2 (en) 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Also Published As

Publication number Publication date
SG11202105227QA (en) 2021-06-29
DK3883647T3 (da) 2026-03-23
MX2021005423A (es) 2021-09-08
ES3063764T3 (en) 2026-04-20
IL283194A (en) 2021-06-30
IL283194B1 (en) 2024-11-01
PT3883647T (pt) 2026-02-26
EP3883647B1 (en) 2026-02-11
KR20210133950A (ko) 2021-11-08
JP2022507776A (ja) 2022-01-18
EP3883647A1 (en) 2021-09-29
IL283194B2 (en) 2025-03-01
SMT202600094T1 (it) 2026-03-09
US20230093692A1 (en) 2023-03-23
AU2019385333A1 (en) 2021-07-01
CN113573779A (zh) 2021-10-29
US12552825B2 (en) 2026-02-17
KR102929869B1 (ko) 2026-02-23
CA3120148A1 (en) 2020-05-28
AU2019385333B2 (en) 2025-04-17
LT3883647T (lt) 2026-03-25
EP4737470A2 (en) 2026-05-06
JP7551610B2 (ja) 2024-09-17
JP2025000636A (ja) 2025-01-07
FI3883647T3 (fi) 2026-03-25
BR112021009624A2 (pt) 2021-08-10
WO2020106627A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
GB2579739B (en) Integrated surveillance and control
EP3681888A4 (en) PYRAZOLOPYRIMIDINONE COMPOUNDS AND THEIR USES
SG11202000356VA (en) Macrocyclic compounds and uses thereof
IL277502A (en) Compounds and uses for them
IL283185A (en) Macrolides with 13 members converted to C10-cyclic and their uses
IL278973A (en) New benzodiazepine histories and uses
IL288991A (en) A macrocyclic compound and its uses
PT3545158T (pt) Portão rolante
IL283194A (en) Macrolides with 13 members converted to C10-alkylene and their uses
IL279483A (en) Cyanotriazole compounds and their uses
SG11202008543RA (en) Pyrrolidineamide derivatives and uses thereof
GB202004930D0 (en) Composition and uses thereof
EP3713575A4 (en) POLYMORPHS AND THEIR USES
HK40038554A (en) Polymorphs and uses thereof
GB201815546D0 (en) Composition and uses thereof
GB201810121D0 (en) Macrocyclic compounds and uses thereof
HK40023320A (en) Pyrazolopyrimidinone compounds and uses thereof
HK40030347A (en) Azaindolylpyridone and diazaindolylpyridone compounds
HK40032561A (en) Macrocyclic compounds and uses thereof
GB201805096D0 (en) Composition and uses thereof
HK40011212A (en) Hsd17b13 variants and uses thereof
GB201803306D0 (en) Door construction
AU2017903793A0 (en) Composition and Uses Thereof
AU2017900749A0 (en) The Door Stay